ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Seattle Cancer Care Alliance Outpatient Clinic to Open – Jan. 19, 2001

June 7, 2021

Worker Health RFA May Finally Be Ready

August 26, 1988

NCI CTEP Approved Trials For the Month of July

July 26, 2013

NCI Programs: Contract Awarded For Geographic Information System

May 14, 1999

Elias Zerhouni Nominated for NIH Director; Richard Carmona For Surgeon General

April 5, 2002

Cancer Letter Goes On Vacation

August 16, 1985